CLINICAL_TRIALS
trial_result
· 2019-06-28
Clinical Trial Update: Safety and Tolerability of Oxymetazoline and Energy-Based Therapy in Participants With Rosacea [Phase 4]
Summary
Phase 4 clinical trial updating safety and tolerability of oxymetazoline combined with energy-based therapy in rosacea.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aclaris Therapeutics, Inc. | Conditions: Rosacea | Phase 4 | Status: COMPLETED | Results posted: 2019-06-28